Development of bis-thiazoles as inhibitors of triosephosphate isomerase from Trypanosoma cruzi. Identification of new non-mutagenic agents that are active in vivo
作者:Guzmán Álvarez、Jennyfer Martínez、Javier Varela、Estefania Birriel、Eugenia Cruces、Martín Gabay、Sandra M. Leal、Patricia Escobar、Beatriz Aguirre-López、Nallely Cabrera、Marietta Tuena de Gómez-Puyou、Armando Gómez Puyou、Ruy Pérez-Montfort、Gloria Yaluff、Susana Torres、Elva Serna、Ninfa Vera de Bilbao、Mercedes González、Hugo Cerecetto
DOI:10.1016/j.ejmech.2015.06.018
日期:2015.7
Triosephosphate isomerase from Trypanosoma cruzi (TcTIM), the etiologic agent of this disease, has been proposed as a druggable target. Some bis-benzothiazoles have been described as irreversible inhibitors of this enzyme. On the other hand, new bioactive furane-containing thiazoles have been described as excellent in vivo anti-T. cruzi agents. This encouraged us to design and develop new bis-thiazoles with potential
被忽视的疾病美国锥虫病是拉丁美洲的主要健康问题之一。已经提出了来自该病的病原体克氏锥虫(Tc TIM)的磷酸三糖异构酶作为可药物治疗的靶点。一些双苯并噻唑被描述为该酶的不可逆抑制剂。另一方面,已将新型的具有生物活性的含呋喃的噻唑描述为极好的体内抗克鲁维氏菌剂。这鼓励我们设计和开发新的双噻唑类药物,有可能用作美国锥虫病的药物。双-噻唑5,3,3'-烯丙基-2,2'-双[3-(2-呋喃基)-2- propenylidenehydrazono] -2,2',3,3'-四氢-4,4'-联噻唑,表现最好体外抗克氏锥虫 谱具有比参比药物Nifurtimox和Benznidazole更高的选择性指数,可对抗寄生虫的a药形式。该衍生物显示边际活性对锝TIM然而双-噻唑14,3-烯丙基-2- [3-(2-呋喃基)-2- propenylidenehydrazono] -3'-苯基-2' - (3-苯基-2-丙二烯二氢偶氮]